CEO of Beigene (30-Year Financial, Insider Trades) John Oyler (insider trades) sold 42,968 shares of BGNE on 08/14/2020 at an average price of $212.71 a share. The total sale was $9.1 million.
BeiGene Ltd is a biopharmaceutical company engaged in the discovery and development of molecularly targeted and immuno-oncology drugs for the treatment of cancer. Its product includes BGB-3111, BGB-A317 and BGB-290 and one immuno-oncology agent. BeiGene Ltd has a market cap of $18.86 billion; its shares were traded at around $210.72 with and P/S ratio of 63.66. GuruFocus has detected 5 severe warning signs with BeiGene Ltd. .
CEO Recent Trades:
- CEO John Oyler sold 42,968 shares of BGNE stock on 08/14/2020 at the average price of $212.71. The price of the stock has decreased by 0.94% since.
- CEO John Oyler sold 17,254 shares of BGNE stock on 08/05/2020 at the average price of $223.27. The price of the stock has decreased by 5.62% since.
- CEO John Oyler sold 40,559 shares of BGNE stock on 08/04/2020 at the average price of $221.27. The price of the stock has decreased by 4.77% since.
- CEO John Oyler sold 27,748 shares of BGNE stock on 07/22/2020 at the average price of $238.34. The price of the stock has decreased by 11.59% since.
- CEO John Oyler sold 55,175 shares of BGNE stock on 07/21/2020 at the average price of $251.84. The price of the stock has decreased by 16.33% since.
Directors and Officers Recent Trades:
- Director Timothy Yung-cheng Chen sold 7,000 shares of BGNE stock on 08/12/2020 at the average price of $212.92. The price of the stock has decreased by 1.03% since.
- Chair, Scientific Advisory Brd Xiaodong Wang sold 4,000 shares of BGNE stock on 08/10/2020 at the average price of $211.06. The price of the stock has decreased by 0.16% since.
- CMO, Hematology Jane Huang sold 3,000 shares of BGNE stock on 07/29/2020 at the average price of $209.93. The price of the stock has increased by 0.38% since.
- President & GM China Xiaobin Wu sold 3,300 shares of BGNE stock on 07/20/2020 at the average price of $249.22. The price of the stock has decreased by 15.45% since.
- Chair, Scientific Advisory Brd Xiaodong Wang sold 17,000 shares of BGNE stock on 07/20/2020 at the average price of $251.51. The price of the stock has decreased by 16.22% since.
For the complete insider trading history of BGNE, click here
.
